HPV vaccine implementation in STD clinics-STD surveillance network

Elissa Meites, Eloisa Llata, Susan Hariri, Jonathan Zenilman, Lisa Longfellow, Jane Schwebke, Irina Tabidze, Christie Mettenbrink, Heidi Jenkins, Sarah Guerry, Preeti Pathela, Lenore Asbel, Jeffrey A. Stover, Kyle Bernstein, Roxanne P. Kerani, Eileen F. Dunne, Lauri E. Markowitz

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


We surveyed selected public sexually transmitted disease clinics in the United States regarding human papillomavirus vaccine availability, target populations, funding sources, and barriers. Although nearly all had experience offering other vaccines, only 7 of 42 clinics (17%) offered human papillomavirus vaccine. Vaccine cost, staff time, and follow-up issues were commonly reported barriers.

Original languageEnglish (US)
Pages (from-to)32-34
Number of pages3
JournalSexually transmitted diseases
Issue number1
StatePublished - Jan 2012

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'HPV vaccine implementation in STD clinics-STD surveillance network'. Together they form a unique fingerprint.

Cite this